BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15840772)

  • 1. Insulin resistance in critically ill patients with acute renal failure.
    Basi S; Pupim LB; Simmons EM; Sezer MT; Shyr Y; Freedman S; Chertow GM; Mehta RL; Paganini E; Himmelfarb J; Ikizler TA
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F259-64. PubMed ID: 15840772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS; Courneya KS; Field CJ; Bell GJ; Jones LW; Mackey JR
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):721-7. PubMed ID: 12917202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum insulin and insulin-like growth factor binding protein-1 levels in adult patients undergoing peritoneal dialysis.
    Iglesias P; Grande C; Méndez J; Fernandez-Reyes MJ; Bajo MA; Selgas R; Díez JJ
    Adv Perit Dial; 1996; 12():71-6. PubMed ID: 8865877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in the insulin-like growth factor axis response to a glucose load.
    Flanagan DE; Holt RI; Owens PC; Cockington RJ; Moore VM; Robinson JS; Godsland IF; Phillips DI
    Acta Physiol (Oxf); 2006 Jul; 187(3):371-8. PubMed ID: 16776662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glycaemia control in critically ill patients is justified and effective].
    Rybka J
    Vnitr Lek; 2010 Sep; 56(9 Suppl):977-87. PubMed ID: 21137171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure.
    Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y
    Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
    Axelsson J; Qureshi AR; Divino-Filho JC; Bárány P; Heimbürger O; Lindholm B; Stenvinkel P
    Eur J Clin Nutr; 2006 Jun; 60(6):718-26. PubMed ID: 16391585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in complexity of glycemic profile in survivors and nonsurvivors in an intensive care unit: a pilot study.
    Lundelin K; Vigil L; Bua S; Gomez-Mestre I; Honrubia T; Varela M
    Crit Care Med; 2010 Mar; 38(3):849-54. PubMed ID: 20068460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients.
    Meyer B; Huelsmann M; Wexberg P; Delle Karth G; Berger R; Moertl D; Szekeres T; Pacher R; Heinz G
    Crit Care Med; 2007 Oct; 35(10):2268-73. PubMed ID: 17717488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of insulin resistance in critically ill medical patients.
    Zauner A; Nimmerrichter P; Anderwald C; Bischof M; Schiefermeier M; Ratheiser K; Schneeweiss B; Zauner C
    Metabolism; 2007 Jan; 56(1):1-5. PubMed ID: 17161218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality.
    Meyfroidt G; Keenan DM; Wang X; Wouters PJ; Veldhuis JD; Van den Berghe G
    Crit Care Med; 2010 Apr; 38(4):1021-9. PubMed ID: 20124887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of blood glucose fluctuations on prognosis of critically ill patients in intensive care unit].
    Yu ZX; Gu Q; Zheng YS; Liu N
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Aug; 21(8):466-9. PubMed ID: 19695167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of admission hyperglycemia or hypoalbuminemia on need ventilator, time ventilated, mortality, and morbidity in critically ill trauma patients.
    Safavi M; Honarmand A
    Ulus Travma Acil Cerrahi Derg; 2009 Mar; 15(2):120-9. PubMed ID: 19353313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance.
    Shmueli E; Miell JP; Stewart M; Alberti KG; Record CO
    Hepatology; 1996 Jul; 24(1):127-33. PubMed ID: 8707251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose metabolism, not obesity, predicts mortality in critically ill surgical patients.
    Mowery NT; May AK; Collier BC; Dossett LA; Gunter OL; Dortch MJ; Diaz JJ
    Am Surg; 2010 Dec; 76(12):1377-83. PubMed ID: 21265352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No decrease in free IGF-I with increasing insulin in obesity-related insulin resistance.
    Ricart W; Fernández-Real JM
    Obes Res; 2001 Oct; 9(10):631-6. PubMed ID: 11595780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased 24 h mean insulin-like growth factor binding protein-3 proteolytic activity in pubertal type 1 diabetic boys.
    Zachrisson I; Brismar K; Carlsson-Skwirut C; Dahlquist G; Wallensteen M; Bang P
    Growth Horm IGF Res; 2000 Dec; 10(6):324-31. PubMed ID: 11161963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.